Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04240392 · ClinicalTrials.gov registry record · NA
Treatment of Pregnant Women With OUD
A NA study of Opioid Use Disorder, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 11
- Study locations
NCT04240392: Completed NA study of Opioid Use Disorder, sponsored by Yale University.
NCT04240392 is a NA study of Opioid Use Disorder that has completed, run by Yale University. The registered enrollment target is 230 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 11 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04240392, a NA study of Opioid Use Disorder, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 11
- Study locations
Study Summary
The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)
Primary Outcome
Dichotomous - A participant completes engagement if the baseline assessment is completed and the participant has had greater than 2 visits for treatment of OUD
Conditions Studied
Interventions
- BEHAVIORAL Collaborative Care (CC)
- BEHAVIORAL Extension for Community Healthcare Outcomes (ECHO)
Study Locations (11)
Connecticut
- Hartford Hospital - Hartford
- Hospital of Central CT - New Britain
- Yale New Haven Hospital Maternal Fetal Medicine Unit - New Haven
- Yale New Haven Hospital Women's Center/Hill Health Center - New Haven
- Coastal ObGyn & Midwifery - New London
- OB Gyn Services PC - Norwich
Massachusetts
- Essex County ObGyn - Beverly
- Beth Israel Deaconess Medical Center - Boston
- AFA Obstetrics & Gynecology - Concord
- Women's Health, Lowell General Hospital - Lowell
- Wesson's Women's Clinic UMASS Baystate - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2020-06-18 |
| Est. Completion | 2024-10-10 |
| Phase | NA |
What the finished NCT04240392 record still lists
NCT04240392 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Collaborative Care (CC) is the first listed.
NCT04240392 lists 11 locations in 2 states (Connecticut, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT04240392 about?
NCT04240392 is a clinical study titled "Treatment of Pregnant Women With OUD". The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)
What is the current status of trial NCT04240392?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2020-06-18. Estimated completion is 2024-10-10.
What conditions does trial NCT04240392 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04240392?
The interventions under investigation include: Collaborative Care (CC) (BEHAVIORAL), Extension for Community Healthcare Outcomes (ECHO) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04240392?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04240392 being conducted?
This trial has 11 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04240392's enrollment target sits among peer trials
230 79th of 257 higher than 178 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI